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OBJECTIVES: Breast hamartoma is an uncommon breast tumor that accounts for approximately 4.8% of all
benign breast masses. The pathogenesis is still poorly understood and breast hamartoma is not a well-known
disorder, so its diagnosis is underestimated by clinicians and pathologists. This study was designed to present
our experience with breast hamartoma, along with a literature review.
METHOD: We reviewed the demographic data, pathologic analyses and imaging and results of patients
diagnosed with breast hamartoma between December 2003 and September 2013.
RESULTS: In total, 27 cases of breast hamartoma operated in the Ankara University Medicine Faculty’s
Department of General Surgery were included in the study. All patients were female and the mean age was
41.8¡10.8 years. The mean tumor size was 3.9¡2.7 cm. Breast ultrasound was performed on all patients before
surgery. The most common additional lesion was epithelial hyperplasia (22.2%). Furthermore, lobular
carcinoma in situ was identified in one case and invasive ductal carcinoma was observed in another case.
Immunohistochemical staining revealed myoid hamartoma in one case (3.7%).
CONCLUSION: Breast hamartomas are rare benign lesions that may be underdiagnosed because of the
categorization of hamartomas as fibroadenomas by pathologists. Pathologic examinations can show variability
from one case to another. Thus, the true incidence may be higher than the literature indicates.
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& INTRODUCTION
Breast hamartoma is an uncommon breast tumor that
accounts for approximately 4.8% of all benign breast masses
(1) and that contains lobular breast tissue involving various
fibrous, fibrocystic and adipose tissues (2). However, with
increasing social awareness and widespread breast cancer
screening, hamartomas are being routinely diagnosed with
greater frequency. The pathogenesis of hamartomas remains
unclear and its diagnosis is underestimated by clinicians
and pathologists. In the literature, breast hamartoma is
presented only in case reports and reviews of wide series
are very rare. Thus, this study was designed to present the
clinicopathologic findings of twenty-seven patients with
breast hamartoma.
& METHODS
Between December 2003 and September 2013, 27 cases of
breast hamartoma operated in the Ankara University
Medicine Faculty’s Department of General Surgery were
included in this study. The histopathology records, clinical
follow-up data and previous breast imaging results of the
patients were obtained. These data were again analyzed and
annotated by clinicians and pathologists.
& RESULTS
Demographic features, tumor sizes, preoperative imaging
procedures, pathologic results and treatment modalities are
shown in Table 1. Clinically, most (24) patients had painless,
soft-to-firm, palpable breast lumps and three patients had
breast asymmetry. Breast ultrasonography (US) was per-
formed on all of the patients as the first preoperative
imaging procedure. In addition to US, mammography was
performed in 6 cases and magnetic resonance imaging
Copyright  2014 CLINICS – This is an Open Access article distributed under
the terms of the Creative Commons Attribution Non-Commercial License (http://
creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-
commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.




(MRI) was conducted in one case. In total, 23 cases showed
features characteristic of fibroadenoma or hamartoma. In 4
patients (14.8%), US revealed a partial irregular border, and
fine-needle aspiration cytology (FNAC) was performed and
revealed benign lesions. Pathologic examination usually
revealed a well-circumscribed mass with normal breast
components, such as a terminal ductal lobular unit, fat and
a hyalinized stroma (Figures 1A-B). The lesions usually
showed fibrocystic changes, columnar cell changes and
adenosis. No proliferative lesions were observed in 14
patients (51.9%). The most common additional proliferative
lesion was ductal epithelial hyperplasia, which was diag-
nosed in 6 patients (22.2%) (Figure 2). We identified lobular
carcinoma in situ (LCIS) in one case and invasive ductal
carcinoma (IDC) in another case, near the breast hamartoma
(3.7%). Pseudoangiomatous hyperplasia was observed in 7
cases (25.9%) (Figure 3). One case (3.7%) was pathologically
reported as breast myoid hamartoma and this hamartoma
stained positive for desmin, smooth muscle actin (SMA) and
CD34 (Figures 4A-C). Mastectomy and sentinel lymph node
biopsy were performed on the patient with IDC and
lumpectomies were performed on the other patients.
& DISCUSSION
Breast hamartomas are poorly defined, rare, benign
breast neoplasms. Hamartomas were initially defined as
mastomas in 1928 by Prym (3). Afterward, several cases
were reported and classified as adenolipomas, fibroadeno-
lipomas or lipofibroadenomas (4). Arrigoni et al. (5) first
used the term hamartoma in 1971. Hamartoma is referred to
as myoid hamartoma, a rarer form, when it shows a
significant smooth muscle component. This term was first
used by Davies and Riddell (6) in 1973.
Articles related to breast hamartoma in the literature are
mostly case reports and rarely case series; therefore, they are
Table 1 - Demographics and clinicopathologic features of
27 patients with breast hamartoma.
Number of patients 27
Age, mean ¡ SD (min-max) 41.8¡10.8 (19-56 years)
Gender Female (all)
Tumor size, mean ¡ SD (min-max) 3.9¡2.7 (0.3-15 cm)
Additional lesion
Ductal epithelial hyperplasia 6 (22.2%)
Pseudoangiomatous hyperplasia 7 (25.9)
LCIS 1 (3.4%)
IDC 1 (3.4%)











Mastectomy + SLNB 1 (3.4%), second surgery for IDC
SD: standard deviation, LCIS: lobular carcinoma in situ, IDC: invasive ductal
carcinoma, SMA: smoothmuscleactin, FNAC: fine-needle aspiration cytology,
MRI: magnetic resonance imaging, SLNB: sentinel lymph node biopsy.
Figure 2 - Ductal epithelial hyperplasia, (H&E),6100.
Figure 1 - (A) and (B) Well-circumscribed mass with normal
terminal ductal lobuler unit, fat and hyalinized stroma,
Hematoksilen Eosin (H&E),640.
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limited in number. Thus, there are few data about these
tumors. We compiled the published case reports and case
series in PubMed from between 1993 and 2013 in terms of
demographic features, tumor size, applied imaging proce-
dures, pathology reports and the results of additional
staining, which are shown in Table 2 (7-43).
The incidence of breast hamartoma among benign breast
tumors was reported to be 4.8% by Charpin et al. (1) in a
large case series in 1994. In total, 27 hamartomas (3.1%) were
diagnosed among 864 benign breast tumors at our center
over the last ten years. In the literature (23,28,29,31,33,
34,37,40-42) the average age of the patients with breast
hamartoma ranged between 33.5 and 66.5 years. In our
study, the age range was from 19-56 years and the mean age
was 41.8 years. There was only one patient under 20 years of
age and 7 patients were over 50 years of age.
The etiopathogenesis of breast hamartomas is not clear
but they are thought to result from dysgenesis (44) rather
than a true tumorous process. However, female sex steroid
hormones (34) have been implicated in the development of
breast hamartomas. In one study, Herbert et al. (33) reported
estrogen receptor (ER) and progesterone receptor (PR)
positivity in epithelial cells and stromal cells in all 24 cases
with breast hamartomas. Additionally, there are no clear
data on the source of smooth muscle for myoid hamarto-
mas, but this muscle could derive from vessels, the nipples,
undifferentiated breast stromal tissue or myoepithelial cells
(4,14). Another hypothesized smooth muscle source is the
metaplasia of breast stromal cells (14) into smooth muscle
cells. The existence of CD34 on smooth muscles (21,34)
is an important sign of the metaplasia of stromal cells
into smooth muscle cells, but there are no clear data on
this subject. Myoid hamartomas stain strongly positive for
SMA, desmin and vimentin (8) by immunohistochemical
staining. In our study, only 1 patient of 27 was diagnosed
with myoid hamartoma and immunohistochemical staining
for desmin, SMA and CD34 was positive, consistent with
the literature.
With increasing social awareness and the use of numer-
ous diagnostic procedures on breast lumps, including
mammography, ultrasound, and MRI, it is expected that
more hamartomas will be reported. Breast hamartomas
have a typical mammographic appearance. The radiolucent
lesions include fat; various amounts of fibrous and
adenomatous tissues, with smooth rims; and occasionally,
a thin capsule (4). US evaluates breast hamartomas as
having sonolucent fat and a heterogeneous internal echo
pattern with echogenic fibrous components (45). Alongside
US, MRI characteristically shows a smooth and well-defined
hypointense rim, internal heterogeneous enhancement and
the presence of fat density (34). In the present study, US was
Figure 3 - Pseudo-angiomatous hyperplasia, (H&E),640.
Figure 4 - Myoid hamartoma, (A) (H&E),640 (B) desmin,640, (C)
SMA,640.
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used for all patients as the first imaging procedure and in
addition to US, mammography was utilized for 6 patients.
MRI was used only for 1 patient with IDC.
The pathologic features of hamartomas are not well
known. The original definition consisted of a fibrous fatty
stroma including various amounts of epithelial elements, as
well as nodular lesions. The fibrous and fatty tissues were
used for the early classification of hamartomas: McGuire
et al. (46) classified breast hamartomas as fibrous, fatty
or fibrous-fatty. Jones et al. (47) suggested 4 classification
groups for breast hamartomas: encapsulated fibrocystic
changes, fibroadenoma with a fibrous stroma, fibroade-
noma-like and surrounded adenolipoma. These classifica-
tions were not widely accepted. No criteria with detailed
explanations of breast hamartomas are used by pathologists.
Fechner et al. (48) described the lobular distribution and the
presence of fat in breast hamartomas as distinguishing
features compared with fibroadenomas. A fibrotic stroma
surrounding the lobules and extending into the interlobular
areas, causing obliteration, is the most frequently observed
feature; most authors (2,47,48) refer to this feature as
interlobular fibrosis. However, interlobular fibrosis is not
specific to breast hamartomas. In sclerosing hyperplasia, an
increasing number of interlobular glands are observed as
round masses with interlobular fibrosis, which can mimic
breast hamartomas. The absence of fatty tissue in the
stromal structure is often associated with fibroadenomas,
so this condition can be distinguished from sclerosing
lobular hyperplasia and breast hamartomas (33,34,45).
Fischer et al. (2) defined the presence of a pseudoangioma-
tous stroma particularly in breast hamartomas. This con-
dition was revealed to be a consistent observation in
subsequent reports and the incidence rate (34,49) varied
between 16 and 71% (34). We also found the rate to be 25.9%
in our series, in line with the literature.
Malignancies associated with breast hamartomas (9,11,
16,29,31,42,50) are rarely observed, and only a few studies
have reported invasive breast cancer associated with breast
hamartoma. We identified IDC in only 1 case and LCIS
in 1 other case. Although epithelial hyperplasia is not a
characteristic feature of breast hamartomas, ductal epithelial
hyperplasia was identified in 6 cases (22.2%). Wahner-
Rodler et al. (37) reported this incidence rate as 26% in their
large case series. These high coincidence rates are very
important. Patients with a certain or suspected diagnosis of
hamartoma must be operated and these patients should
never be followed, even if their tumors are small.
In conclusion, we present our institutional experience
with breast hamartomas in 27 patients. Although breast
hamartomas are rare, benign lesions, these lesions can reach
large sizes. A diagnosis can be made by core needle biopsy,
along with an appropriate correlation of clinical and
radiologic features. Breast hamartomas may be under-
diagnosed because pathologists may categorize these
lesions as fibroadenomas instead of hamartomas. Thus,
the true incidence may be higher than the literature
indicates.
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